Cleared in Nearly 70 Jurisdictions and Still Unable to Close: The Paramount Warner Bros. Position in Mid August

The announcement

In mid August, on or about August 14, Paramount Skydance announced that it had satisfied all regulatory conditions required under its merger agreement to close the Warner Bros. Discovery acquisition.

The company described an approximately eight month review process spanning roughly 68 jurisdictions, including the United States, the European Union and China, and said regulators had consistently found no basis to prevent the transaction from moving forward. The United Kingdom's Competition and Markets Authority cleared the takeover in the same month.

For a transaction of roughly $111 billion at $31.00 per share in cash, clearing that many jurisdictions in eight months is a genuinely fast result.

And the deal still cannot close.

Why clearance is not permission

The reason is the postponement agreement from July 24, under which Paramount agreed with twelve state attorneys general to hold the close until five days after an antitrust trial concludes, or June 1, 2027, whichever comes first.

This produces a situation worth understanding properly, because it is becoming more common rather than less.

Regulatory clearance and litigation risk are separate tracks. A competition authority reviewing a merger decides whether to challenge it. If it declines, the merger is cleared from that authority's perspective. That decision does not bind anyone else. State attorneys general have independent antitrust authority, private plaintiffs can sue, and labour organisations can bring their own claims. The Writers Guild of America has done so here.

So a company can do everything the regulators ask, in every jurisdiction that matters, and arrive at a position where the only remaining obstacle is a courtroom it cannot clear administratively.

What this tells you about merger risk in this sector

The traditional model of merger risk in media was regulatory: get the agencies comfortable and the deal closes. Boards, bankers and rights holders all planned on that basis.

This transaction demonstrates a different model. Regulatory approval has become, if not routine, then at least tractable, and the binding constraint has shifted to litigation brought by parties that regulators do not control.

Three implications follow for anyone whose business depends on who owns what.

Deal timelines are less predictable, in both directions. Regulatory review has a rhythm, with defined phases and statutory clocks. Litigation does not. A trial date can move for reasons entirely unrelated to the merits.

Regulatory clearance is a weak signal about closing. If you are planning around a transaction, the fact that it has cleared its regulators tells you considerably less than it used to.

The parties most likely to sue are labour and states, not competitors. That changes what the challenges are about. Competitor complaints concern foreclosure and pricing. Labour and state challenges concern employment, local economic impact and, as here, concentration in ways that touch consumers and creative workers. Different theories, different evidence, different remedies.

The remedy scenario, again

We flagged this earlier in the month and it is worth repeating, because it is the outcome most likely to matter to licensors and the least discussed.

Contested media mergers frequently resolve through negotiated remedies rather than a verdict. In this sector, remedies commonly take the form of behavioural commitments about licensing: undertakings to continue licensing content to third parties on non discriminatory terms, to honour existing output arrangements, or to divest particular assets.

If this matter resolves that way, the resulting commitments would directly govern how the combined library is licensed to third parties for a defined period. For rights holders and for competing platforms, those terms would be the single most consequential output of the entire process.

They would also arrive as a consent decree or settlement document rather than as a headline, which means the people most affected are the least likely to read them.

What has not changed

Two things are unchanged despite the milestone.

The two companies remain independent competitors and must behave as such until closing. For sellers with a title both would want, that competitive dynamic is intact.

And the ticking fee continues to run. If the transaction has not closed by September 30, 2026, which is now effectively certain, Warner Bros. Discovery shareholders accrue $0.25 per share for each quarter until it does.

The read for rights holders

Do not treat the regulatory milestone as a signal that consolidation is imminent. It is not. The close is bounded by a litigation timetable that runs into 2027 at the earliest.

Do treat it as confirmation that the transaction is more likely than not to happen eventually. A buyer that has cleared nearly 70 jurisdictions and negotiated a delay rather than walking away is a buyer that intends to close.

The planning posture that follows is the one we have described throughout this month. Use the remaining window while there are two buyers. Know your change of control exposure. Decide term length deliberately rather than by default. And know, precisely, what share of your licensing revenue sits with these two counterparties combined, because after this closes that is a single relationship rather than two.